PortfoliosLab logoPortfoliosLab logo
TMDX vs. CB
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

TMDX vs. CB - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in TransMedics Group, Inc. (TMDX) and Chubb Limited (CB). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, TMDX achieves a -40.07% return, which is significantly lower than CB's 5.77% return.


TMDX

1D
-0.92%
1M
15.36%
YTD
-40.07%
6M
-42.50%
1Y
-48.97%
3Y*
-4.58%
5Y*
20.83%
10Y*

CB

1D
0.38%
1M
1.55%
YTD
5.77%
6M
7.02%
1Y
15.88%
3Y*
21.39%
5Y*
16.27%
10Y*
12.26%
*Multi-year figures are annualized to reflect compound growth (CAGR)

TMDX vs. CB - Yearly Performance Comparison


2026 (YTD)2025202420232022202120202019
TMDX
TransMedics Group, Inc.
-40.07%95.11%-21.01%27.88%222.13%-3.72%4.68%-6.12%
CB
Chubb Limited
5.77%14.46%23.89%4.20%15.97%27.85%1.41%9.51%

Correlation

The correlation between TMDX and CB is 0.01, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.01

Correlation (3Y)
Calculated over the trailing 3-year period

-0.02

Correlation (5Y)
Calculated over the trailing 5-year period

0.08

Correlation (All Time)
Calculated using the full available price history since May 2, 2019

0.10

The correlation between TMDX and CB shifts across timeframes, from -0.02 (3 years) to 0.10 (all time), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

TMDX:

$2.64B

CB:

$129.48B

EPS

TMDX:

$4.34

CB:

$28.35

PE Ratio

TMDX:

16.80

CB:

11.58

PEG Ratio

TMDX:

0.04

CB:

0.80

PS Ratio

TMDX:

4.54

CB:

2.72

PB Ratio

TMDX:

5.34

CB:

1.62

Total Revenue (TTM)

TMDX:

$635.89M

CB:

$48.15B

Gross Profit (TTM)

TMDX:

$375.74M

CB:

$17.01B

EBITDA (TTM)

TMDX:

$125.51M

CB:

$12.22B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

TMDX vs. CB — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

TMDX
TMDX Risk / Return Rank: 88
Overall Rank
TMDX Sharpe Ratio Rank: 99
Sharpe Ratio Rank
TMDX Sortino Ratio Rank: 1010
Sortino Ratio Rank
TMDX Omega Ratio Rank: 1111
Omega Ratio Rank
TMDX Calmar Ratio Rank: 1010
Calmar Ratio Rank
TMDX Martin Ratio Rank: 11
Martin Ratio Rank

CB
CB Risk / Return Rank: 6969
Overall Rank
CB Sharpe Ratio Rank: 7171
Sharpe Ratio Rank
CB Sortino Ratio Rank: 6565
Sortino Ratio Rank
CB Omega Ratio Rank: 6363
Omega Ratio Rank
CB Calmar Ratio Rank: 7272
Calmar Ratio Rank
CB Martin Ratio Rank: 7272
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

TMDX vs. CB - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for TransMedics Group, Inc. (TMDX) and Chubb Limited (CB). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


TMDXCBDifference
Sharpe ratioReturn per unit of total volatility

-1.72

Sortino ratioReturn per unit of downside risk

-2.52

Omega ratioGain probability vs. loss probability

0.86

1.17

-0.31

Calmar ratioReturn relative to maximum drawdown

-0.84

1.64

-2.48

Martin ratioReturn relative to average drawdown

-1.99

3.73

-5.72

TMDX vs. CB - Sharpe Ratio Comparison

The current TMDX Sharpe Ratio is -0.85, which is lower than the CB Sharpe Ratio of 0.87. The chart below compares the historical Sharpe Ratios of TMDX and CB, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

TMDX vs. CB - Drawdown Comparison

The maximum TMDX drawdown since its inception was -73.69%, which is greater than CB's maximum drawdown of -50.99%. Use the drawdown chart below to compare losses from any high point for TMDX and CB.


Loading charts...

Drawdown Indicators


TMDXCBDifference

Max Drawdown

Largest peak-to-trough decline

-73.69%

-50.99%

-22.70%

Max Drawdown (1Y)

Largest decline over 1 year

-58.76%

-9.36%

-49.40%

Max Drawdown (3Y)

Largest decline over 3 years

-67.79%

-14.35%

-53.44%

Max Drawdown (5Y)

Largest decline over 5 years

-67.79%

-19.26%

-48.53%

Max Drawdown (10Y)

Largest decline over 10 years

-42.59%

Current Drawdown

Current decline from peak

-58.60%

-3.68%

-54.92%

Average Drawdown

Average peak-to-trough decline

-31.89%

-10.68%

-21.21%

Ulcer Index

Depth and duration of drawdowns from previous peaks

24.65%

4.11%

+20.54%

Volatility

TMDX vs. CB - Volatility Comparison

TransMedics Group, Inc. (TMDX) has a higher volatility of 12.66% compared to Chubb Limited (CB) at 6.08%. This indicates that TMDX's price experiences larger fluctuations and is considered to be riskier than CB based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


TMDXCBDifference

Volatility (1M)

Calculated over the trailing 1-month period

12.66%

6.08%

+6.58%

Volatility (6M)

Calculated over the trailing 6-month period

43.87%

13.12%

+30.75%

Volatility (1Y)

Calculated over the trailing 1-year period

58.06%

17.67%

+40.39%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

72.00%

20.33%

+51.67%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

71.72%

23.69%

+48.03%

Dividends

TMDX vs. CB - Dividend Comparison

TMDX has not paid dividends to shareholders, while CB's dividend yield for the trailing twelve months is around 1.49%.


PositionTTM20252024202320222021202020192018201720162015
CB
Chubb Limited
1.20%1.22%1.30%1.51%1.49%1.65%2.01%1.91%2.24%1.93%2.07%4.23%
TMDX
TransMedics Group, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Financials

TMDX vs. CB - Financials Comparison

This section allows you to compare key financial metrics between TransMedics Group, Inc. and Chubb Limited. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.005.00B10.00B15.00B20222023202420252026
173.93M
1.88B
(TMDX) Total Revenue
(CB) Total Revenue
Values in USD except per share items

Frequently Asked Questions


TMDX and CB have a correlation of 0.01, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

TMDX has higher volatility (12.66%) compared to CB (6.08%). In terms of maximum drawdown, TMDX dropped -73.69% vs CB's -50.99%.

CB currently has the higher Sharpe Ratio (0.87 vs -0.85), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for TMDX and CB

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer